Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada

Cancer

Volumn 117, Issue 16, 2011, Pages 3833-3840

  Lima, Isac S F ^a   Yasui, Yutaka ^a   Scarfe, Andrew ^a,b   Winget, Marcy ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

Author keywords

adjuvant chemotherapy; colon cancer; health services research; outcomes research; survival; timeliness of care; treatment guidelines

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COLON ADENOCARCINOMA; COLON SURGERY; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT CARE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL STATUS; TIMELINESS OF CARE;

ADENOCARCINOMA; AGED; ALBERTA; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; HUMANS; TIME FACTORS;

EID: 79958024180     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25954     Document Type: Article

References (21)

1. NIH consensus conference. adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264: 1444-1450.
2. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990; 322: 352-358. (Pubitemid 20042739)
3. Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006; 107: 2581-2588. (Pubitemid 44845611)
4. Alberta Cancer Board. Early Stage Colon Cancer: Clinical Practice Guideline. Report No. GI-003. Edmonton, Alberta, Canada: Alberta Cancer Board; 2008.
5. Cree M, Tonita J, Turner D, et al. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. Clin Colorectal Cancer. 2009; 8: 141-145.
6. Winget M, Hossain S, Yasui Y, Scarfe A,. Characteristics of stage III colon adenocarcinoma patients who fail to receive guideline-recommended treatment. Cancer. 2010; 116: 4849-4856.
7. Schrag D, Cramer LD, Bach PB, Begg CB,. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001; 93: 850-857. (Pubitemid 32590779)
8. Jessup JM, Stewart A, Greene FL, Minsky BD,. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005; 294: 2703-2711. (Pubitemid 41770099)
9. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003; 21: 1293-1300. (Pubitemid 46606406)
10. Fritz A, Percy C, Jack A, et al. eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
11. Greene FL, Page DL, Fleming ID, et al. eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
12. World Health Organization. Rules and guidelines for morbidity and mortality coding (chap 4). International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Volume 2: Instruction Manual. Geneva, Switzerland: World Health Organization; 1994: 31-68.
13. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43: 1130-1139. (Pubitemid 41587600)
14. Gooley TA, Leisenring W, Crowley J, Storer BE,. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18: 695-706. (Pubitemid 29126745)
15. Durrleman S, Simon R,. Flexible regression models with cubic splines. Stat Med. 1989; 8: 551-561. (Pubitemid 19116001)
16. Iwashyna TJ, Lamont EB,. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002; 20: 3992-3998.
17. Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI,. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002; 136: 349-357. (Pubitemid 34183993)
18. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001; 345: 1091-1097.
19. Zuckerman IH, Rapp T, Onukwugha E, et al. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with stage III colon cancer. J Am Geriatr Soc. 2009; 57: 1403-1410.
20. Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME,. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med. 2006; 145: 646-653. (Pubitemid 46768839)
21. Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC,. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg. 2009; 208: 202-209.